The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Mumps Vaccine Market Research Report 2022

Global Mumps Vaccine Market Research Report 2022

Publishing Date : Jun, 2022

License Type :
 

Report Code : 1711737

No of Pages : 112

Synopsis
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
Due to the COVID-19 pandemic, the global Mumps Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Mumps Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Mumps Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Child accounting for % of the Mumps Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals Pharmacies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Mumps Vaccine include MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited and Emergent BioSolutions, etc. In terms of revenue, the global 3 largest players have a % market share of Mumps Vaccine in 2021.
This report focuses on Mumps Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mumps Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and India, etc.
Global Mumps Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type

  • Child
  • Adult

Segment by Application

  • Hospitals Pharmacies
  • Retail Pharmacies

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

By Company

  • MedImmune
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi
  • Serum Institute of India
  • Bavarian Nordic
  • Astellas Pharma India
  • CSL Limited
  • Emergent BioSolutions
  • GlaxoSmithKline
  • Panacea Biotec, Ltd.
  • Biological E Limited
  • Bharat Biotech Ltd.
  • Novavax, Inc.
  • Novartis
  • Sinovac Biotech, Ltd.
  • Incepta Vaccine Limited
  • Valneva SE
  • VBI Vaccines
  • PT Bio Farma
Index

1 Mumps Vaccine Market Overview
1.1 Product Overview and Scope of Mumps Vaccine
1.2 Mumps Vaccine Segment by Type
1.2.1 Global Mumps Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Child
1.2.3 Adult
1.3 Mumps Vaccine Segment by Application
1.3.1 Global Mumps Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Mumps Vaccine Market Size Estimates and Forecasts
1.4.1 Global Mumps Vaccine Revenue 2017-2028
1.4.2 Global Mumps Vaccine Sales 2017-2028
1.4.3 Mumps Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Mumps Vaccine Market Competition by Manufacturers
2.1 Global Mumps Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Mumps Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Mumps Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Mumps Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Mumps Vaccine Market Competitive Situation and Trends
2.5.1 Mumps Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Mumps Vaccine Players Market Share by Revenue
2.5.3 Global Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mumps Vaccine Retrospective Market Scenario by Region
3.1 Global Mumps Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Mumps Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Mumps Vaccine Market Facts & Figures by Country
3.3.1 North America Mumps Vaccine Sales by Country
3.3.2 North America Mumps Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Mumps Vaccine Market Facts & Figures by Country
3.4.1 Europe Mumps Vaccine Sales by Country
3.4.2 Europe Mumps Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mumps Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Mumps Vaccine Sales by Region
3.5.2 Asia Pacific Mumps Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Mumps Vaccine Market Facts & Figures by Country
3.6.1 Latin America Mumps Vaccine Sales by Country
3.6.2 Latin America Mumps Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Mumps Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mumps Vaccine Sales by Country
3.7.2 Middle East and Africa Mumps Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Mumps Vaccine Historic Market Analysis by Type
4.1 Global Mumps Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Mumps Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Mumps Vaccine Price by Type (2017-2022)
5 Global Mumps Vaccine Historic Market Analysis by Application
5.1 Global Mumps Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Mumps Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Mumps Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 MedImmune
6.1.1 MedImmune Corporation Information
6.1.2 MedImmune Description and Business Overview
6.1.3 MedImmune Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 MedImmune Mumps Vaccine Product Portfolio
6.1.5 MedImmune Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Johnson & Johnson Mumps Vaccine Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Merck & Co., Inc. Mumps Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Mumps Vaccine Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Serum Institute of India Mumps Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bavarian Nordic Mumps Vaccine Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Astellas Pharma India
6.6.1 Astellas Pharma India Corporation Information
6.6.2 Astellas Pharma India Description and Business Overview
6.6.3 Astellas Pharma India Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Astellas Pharma India Mumps Vaccine Product Portfolio
6.7.5 Astellas Pharma India Recent Developments/Updates
6.8 CSL Limited
6.8.1 CSL Limited Corporation Information
6.8.2 CSL Limited Description and Business Overview
6.8.3 CSL Limited Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 CSL Limited Mumps Vaccine Product Portfolio
6.8.5 CSL Limited Recent Developments/Updates
6.9 Emergent BioSolutions
6.9.1 Emergent BioSolutions Corporation Information
6.9.2 Emergent BioSolutions Description and Business Overview
6.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Emergent BioSolutions Mumps Vaccine Product Portfolio
6.9.5 Emergent BioSolutions Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 GlaxoSmithKline Mumps Vaccine Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Panacea Biotec, Ltd.
6.11.1 Panacea Biotec, Ltd. Corporation Information
6.11.2 Panacea Biotec, Ltd. Mumps Vaccine Description and Business Overview
6.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Panacea Biotec, Ltd. Mumps Vaccine Product Portfolio
6.11.5 Panacea Biotec, Ltd. Recent Developments/Updates
6.12 Biological E Limited
6.12.1 Biological E Limited Corporation Information
6.12.2 Biological E Limited Mumps Vaccine Description and Business Overview
6.12.3 Biological E Limited Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Biological E Limited Mumps Vaccine Product Portfolio
6.12.5 Biological E Limited Recent Developments/Updates
6.13 Bharat Biotech Ltd.
6.13.1 Bharat Biotech Ltd. Corporation Information
6.13.2 Bharat Biotech Ltd. Mumps Vaccine Description and Business Overview
6.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Bharat Biotech Ltd. Mumps Vaccine Product Portfolio
6.13.5 Bharat Biotech Ltd. Recent Developments/Updates
6.14 Novavax, Inc.
6.14.1 Novavax, Inc. Corporation Information
6.14.2 Novavax, Inc. Mumps Vaccine Description and Business Overview
6.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Novavax, Inc. Mumps Vaccine Product Portfolio
6.14.5 Novavax, Inc. Recent Developments/Updates
6.15 Novartis
6.15.1 Novartis Corporation Information
6.15.2 Novartis Mumps Vaccine Description and Business Overview
6.15.3 Novartis Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Novartis Mumps Vaccine Product Portfolio
6.15.5 Novartis Recent Developments/Updates
6.16 Sinovac Biotech, Ltd.
6.16.1 Sinovac Biotech, Ltd. Corporation Information
6.16.2 Sinovac Biotech, Ltd. Mumps Vaccine Description and Business Overview
6.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolio
6.16.5 Sinovac Biotech, Ltd. Recent Developments/Updates
6.17 Incepta Vaccine Limited
6.17.1 Incepta Vaccine Limited Corporation Information
6.17.2 Incepta Vaccine Limited Mumps Vaccine Description and Business Overview
6.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Incepta Vaccine Limited Mumps Vaccine Product Portfolio
6.17.5 Incepta Vaccine Limited Recent Developments/Updates
6.18 Valneva SE
6.18.1 Valneva SE Corporation Information
6.18.2 Valneva SE Mumps Vaccine Description and Business Overview
6.18.3 Valneva SE Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Valneva SE Mumps Vaccine Product Portfolio
6.18.5 Valneva SE Recent Developments/Updates
6.19 VBI Vaccines
6.19.1 VBI Vaccines Corporation Information
6.19.2 VBI Vaccines Mumps Vaccine Description and Business Overview
6.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.19.4 VBI Vaccines Mumps Vaccine Product Portfolio
6.19.5 VBI Vaccines Recent Developments/Updates
6.20 PT Bio Farma
6.20.1 PT Bio Farma Corporation Information
6.20.2 PT Bio Farma Mumps Vaccine Description and Business Overview
6.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.20.4 PT Bio Farma Mumps Vaccine Product Portfolio
6.20.5 PT Bio Farma Recent Developments/Updates
7 Mumps Vaccine Manufacturing Cost Analysis
7.1 Mumps Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mumps Vaccine
7.4 Mumps Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mumps Vaccine Distributors List
8.3 Mumps Vaccine Customers
9 Mumps Vaccine Market Dynamics
9.1 Mumps Vaccine Industry Trends
9.2 Mumps Vaccine Market Drivers
9.3 Mumps Vaccine Market Challenges
9.4 Mumps Vaccine Market Restraints
10 Global Market Forecast
10.1 Mumps Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mumps Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Mumps Vaccine by Type (2023-2028)
10.2 Mumps Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mumps Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Mumps Vaccine by Application (2023-2028)
10.3 Mumps Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mumps Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Mumps Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Mumps Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Mumps Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Mumps Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Mumps Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Mumps Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Mumps Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Mumps Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Mumps Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Mumps Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Mumps Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Mumps Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mumps Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mumps Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Mumps Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Mumps Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Mumps Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Mumps Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Mumps Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Mumps Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Mumps Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Mumps Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Mumps Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Mumps Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Mumps Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Mumps Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Mumps Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Mumps Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Mumps Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Mumps Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Mumps Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Mumps Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Mumps Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Mumps Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Mumps Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. MedImmune Corporation Information
Table 50. MedImmune Description and Business Overview
Table 51. MedImmune Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. MedImmune Mumps Vaccine Product
Table 53. MedImmune Recent Developments/Updates
Table 54. Johnson & Johnson Corporation Information
Table 55. Johnson & Johnson Description and Business Overview
Table 56. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Johnson & Johnson Mumps Vaccine Product
Table 58. Johnson & Johnson Recent Developments/Updates
Table 59. Merck & Co., Inc. Corporation Information
Table 60. Merck & Co., Inc. Description and Business Overview
Table 61. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Merck & Co., Inc. Mumps Vaccine Product
Table 63. Merck & Co., Inc. Recent Developments/Updates
Table 64. Sanofi Corporation Information
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sanofi Mumps Vaccine Product
Table 68. Sanofi Recent Developments/Updates
Table 69. Serum Institute of India Corporation Information
Table 70. Serum Institute of India Description and Business Overview
Table 71. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Serum Institute of India Mumps Vaccine Product
Table 73. Serum Institute of India Recent Developments/Updates
Table 74. Bavarian Nordic Corporation Information
Table 75. Bavarian Nordic Description and Business Overview
Table 76. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Bavarian Nordic Mumps Vaccine Product
Table 78. Bavarian Nordic Recent Developments/Updates
Table 79. Astellas Pharma India Corporation Information
Table 80. Astellas Pharma India Description and Business Overview
Table 81. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Astellas Pharma India Mumps Vaccine Product
Table 83. Astellas Pharma India Recent Developments/Updates
Table 84. CSL Limited Corporation Information
Table 85. CSL Limited Description and Business Overview
Table 86. CSL Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. CSL Limited Mumps Vaccine Product
Table 88. CSL Limited Recent Developments/Updates
Table 89. Emergent BioSolutions Corporation Information
Table 90. Emergent BioSolutions Description and Business Overview
Table 91. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Emergent BioSolutions Mumps Vaccine Product
Table 93. Emergent BioSolutions Recent Developments/Updates
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. GlaxoSmithKline Mumps Vaccine Product
Table 98. GlaxoSmithKline Recent Developments/Updates
Table 99. Panacea Biotec, Ltd. Corporation Information
Table 100. Panacea Biotec, Ltd. Description and Business Overview
Table 101. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Panacea Biotec, Ltd. Mumps Vaccine Product
Table 103. Panacea Biotec, Ltd. Recent Developments/Updates
Table 104. Biological E Limited Corporation Information
Table 105. Biological E Limited Description and Business Overview
Table 106. Biological E Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Biological E Limited Mumps Vaccine Product
Table 108. Biological E Limited Recent Developments/Updates
Table 109. Bharat Biotech Ltd. Corporation Information
Table 110. Bharat Biotech Ltd. Description and Business Overview
Table 111. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Bharat Biotech Ltd. Mumps Vaccine Product
Table 113. Bharat Biotech Ltd. Recent Developments/Updates
Table 114. Novavax, Inc. Corporation Information
Table 115. Novavax, Inc. Description and Business Overview
Table 116. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Novavax, Inc. Mumps Vaccine Product
Table 118. Novavax, Inc. Recent Developments/Updates
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Business Overview
Table 121. Novartis Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Novartis Mumps Vaccine Product
Table 123. Novartis Recent Developments/Updates
Table 124. Sinovac Biotech, Ltd. Corporation Information
Table 125. Sinovac Biotech, Ltd. Description and Business Overview
Table 126. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Sinovac Biotech, Ltd. Mumps Vaccine Product
Table 128. Sinovac Biotech, Ltd. Recent Developments/Updates
Table 129. Incepta Vaccine Limited Corporation Information
Table 130. Incepta Vaccine Limited Description and Business Overview
Table 131. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Incepta Vaccine Limited Mumps Vaccine Product
Table 133. Incepta Vaccine Limited Recent Developments/Updates
Table 134. Valneva SE Corporation Information
Table 135. Valneva SE Description and Business Overview
Table 136. Valneva SE Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Valneva SE Mumps Vaccine Product
Table 138. Valneva SE Recent Developments/Updates
Table 139. VBI Vaccines Corporation Information
Table 140. VBI Vaccines Description and Business Overview
Table 141. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. VBI Vaccines Mumps Vaccine Product
Table 143. VBI Vaccines Recent Developments/Updates
Table 144. PT Bio Farma Corporation Information
Table 145. PT Bio Farma Description and Business Overview
Table 146. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. PT Bio Farma Mumps Vaccine Product
Table 148. PT Bio Farma Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Mumps Vaccine Distributors List
Table 152. Mumps Vaccine Customers List
Table 153. Mumps Vaccine Market Trends
Table 154. Mumps Vaccine Market Drivers
Table 155. Mumps Vaccine Market Challenges
Table 156. Mumps Vaccine Market Restraints
Table 157. Global Mumps Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Mumps Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Mumps Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Mumps Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Mumps Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Mumps Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Mumps Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Mumps Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Mumps Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Mumps Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Mumps Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Mumps Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mumps Vaccine
Figure 2. Global Mumps Vaccine Market Share by Type in 2021 & 2028
Figure 3. Child Product Picture
Figure 4. Adult Product Picture
Figure 5. Global Mumps Vaccine Market Share by Application in 2021 & 2028
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Global Mumps Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Mumps Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Mumps Vaccine Sales (2017-2028) & (K Units)
Figure 11. Mumps Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Mumps Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Mumps Vaccine Players: Market Share by Revenue in 2021
Figure 14. Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Mumps Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Mumps Vaccine Sales Market Share by Region in 2021
Figure 17. Global Mumps Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Mumps Vaccine Revenue Market Share by Region in 2021
Figure 19. United States Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Mumps Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Mumps Vaccine by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of Mumps Vaccine
Figure 43. Manufacturing Process Analysis of Mumps Vaccine
Figure 44. Mumps Vaccine Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’